Hypofractionated Radiotherapy Concomitantly With Weekly Boost for Breast Cancer Patients Treated With Conservative Breast Surgery

• Conditions: Breast Cancer

• Registration Number: NCT04815642
• Lead Sponsor: Assiut University

Brief Summary

This is a retrospective study on evaluation of the efficacy and the safety of a hypofractionated radiotherapy course with weekly concomitant boost for breast cancer patients treated with conservative breast surgery .

Detailed Description

Not available

Study Timeline

• Status Verified: 2021-03
• Study First Submitted: 2021-03-23
• Study First Submitted QC: 2021-03-24
• Study First Posted: 2021-03-25
• Last Update Submitted: 2021-08-01
• Last Update Posted: 2021-08-03
• Study Start: 2021-12-01
• Primary Completion: 2023-01-01
• Study Completion: 2023-04-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1. women aged from 18 and up to 55 years old.
2. Histologically diagnosed with breast carcinoma (ductal and others )
3. All patients with conservative breast surgery.
4. Including all patients with in all stages except those stage IV.
5. All patients with clear free surgical margin.
6. patients received hypofractionated radiotherapy with weekly concomitant boost

Exclusion Criteria

1. Evidence of distant metastatic deposites.
2. patients with mastectomy
3. patients with prior irradiation to thoracic region.
4. pregnancy or lactation.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Disease free survival	baseline	Disease Free survival